![](/img/cover-not-exists.png)
Immunotherapy with donor lymphocytes depleted of anti-host reactive cells results in safe and efficacious haploidentical HSCT: interim results from a phase II trial in patients with hematologic malignancies
Roy, D., Maertens, J., Walker, I., Foley, R., Lewalle, P., Selleslag, D., Velthuis, J., Gerez, L., Reitsma, K., Wagena, E., Roy, J., Lachance, S., Mielke, S.Volume:
16
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2014.01.085
Date:
April, 2014
File:
PDF, 129 KB
english, 2014